LoadingFTV
Okerstrom Mark D reported Grant or award in Fortive Corp: 4.88 units of Executive Deferred Incentive Program - Fortive Stock Fund (derivative), dated 2026-09-25. The full Form 4 contains 1 transaction entry.
FTV
Soroye Olumide reported Grant or award in Fortive Corp: 14.917 units of Executive Deferred Incentive Program - Fortive Stock Fund (derivative), dated 2026-09-25. The full Form 4 contains 1 transaction entry.
CBDS
TOBIAS DAVID reported Purchase in Dogecoin Cash, Inc.: 125000.0000 units of Common, dated 2026-09-17. The full Form 4 contains 1 transaction entry.
GTLB
Sijbrandij Sytse reported Sale in Gitlab Inc.: 842084 units of Class A Common Stock, dated 2026-09-24. The full Form 4 contains 7 transaction entries.
HUT
SHATTUCK MAYO A III reported Sale in Hut 8 Corp.: 20000 units of Common Stock, par value $0.01 per share, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
BSBR
Ishii Michele Soares reported Sale in Banco Santander (Brasil) S.A.: 800 units of UNIT - SANB11, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
SONO
Boone Karen reported Exercise or conversion in Sonos Inc: 31766 units of Common Stock, dated 2026-09-25. The full Form 4 contains 4 transaction entries.
BSBR
Saes Edmilson reported Sale in Banco Santander (Brasil) S.A.: 50000 units of UNIT - SANB11, dated 2026-09-22. The full Form 4 contains 1 transaction entry.
XYZ
Eisen Anthony Mathew reported Sale in Block, Inc.: 6000 units of Class A Common Stock, dated 2026-09-24. The full Form 4 contains 3 transaction entries.
GKOS
Navratil Tomas reported Sale in GLAUKOS Corp: 167 units of Common Stock, dated 2026-09-25. The full Form 4 contains 4 transaction entries.
BLLN
ten Bosch John Roderick reported Sale in BillionToOne, Inc.: 1416 units of Class A Common Stock, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
BLLN
Tsao David reported Exercise or conversion in BillionToOne, Inc.: 3333 units of Class A Common Stock, dated 2026-09-24. The full Form 4 contains 3 transaction entries.
RVMD
Mancini Anthony reported Sale in Revolution Medicines, Inc.: 587 units of Common Stock, dated 2026-09-24. The full Form 4 contains 4 transaction entries.
INR
Baetz Cary D reported Purchase in INFINITY NATURAL RESOURCES, INC.: 22000 units of Class A Common Stock, dated 2026-09-24. The full Form 4 contains 2 transaction entries.
PNRG
FONG GIFFORD reported Gift in PRIMEENERGY RESOURCES CORP: 15000 units of COMMON STOCK, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
HNNA
SEAVEY THOMAS L reported Sale in HENNESSY ADVISORS INC: 1875 units of Common Stock, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
EMIS
Emmis Capital Sponsor LLC reported Other (see filing) in Emmis Acquisition Corp.: 11667 units of Class B Ordinary Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
TER
Herweck Peter reported Grant or award in TERADYNE, INC: 77 units of Common Stock, dated 2026-09-24. The full Form 4 contains 2 transaction entries.
GRDN
Mudd William Franklin reported Exercise or conversion in Guardian Pharmacy Services, Inc.: 38282 units of Class A Common Stock, dated 2026-09-27. The full Form 4 contains 2 transaction entries.
VICI
Sullivan John M reported 5,562 shares of Common Stock in VICI PROPERTIES INC. as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
ASAN
Berquist Thomas reported 38,802 shares of Class A Common Stock in Asana, Inc. as grants or awards dated 2026-09-25. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
ASAN
Ting Jerry Hao reported 38,802 shares of Class A Common Stock in Asana, Inc. as grants or awards dated 2026-09-25. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
LXEO
Townsend Richard Nolan reported Grant or award in Lexeo Therapeutics, Inc.: 2306 units of Common Stock, dated 2026-09-14. The full Form 4 contains 2 transaction entries.
LXEO
Otero Jose Manuel reported Grant or award in Lexeo Therapeutics, Inc.: 2110 units of Common Stock, dated 2026-09-14. The full Form 4 contains 2 transaction entries.
